HumanFirst Funding & Investors

HumanFirst enables safe, effective, and equitable healthcare operations at home. Previously known as Elektra Labs, HumanFirst serves leading organizations pioneering decentralized clinical trials and virtual care. Twenty-two of the 25 largest pharmaceutical companies in the world have used the HumanFirst platform to evaluate and enable the deployment of health technology products. HumanFirst offers command center and infrastructure solutions that ensure their telehealth operations are as reliable and trustworthy as those within hospitals or labs. HumanFirst was developed via grants from the National Science Foundation and the Harvard Business School Rock Center for Entrepreneurship, and first launched its Atlas workflow management tool for remote monitoring in 2019. HumanFirst closed a Series A round of funding led by Maverick Ventures, participation from Lux Capital, Threshold Ventures, Arkitekt Ventures, Boost VC, SV Angel, Village Global, and more than 30 angel investors. This investment brings HumanFirst’s total funding to $15M since the company’s inception.